Table 2. Summary of preferred conditions to establish naïve hESC from established primed lines, without transgenes.
Reference by first author | Inhibitors used | growth factors |
---|---|---|
Chan (36) | 2i, dorsomorphin | hLIF |
Gafni (37) | 2i, JNKi, p38MAPKi | hLIF, FGF2, TGFβ1 |
Ware (23) | 2i | FGF2 (HDACi pretreatment*) |
Theunissen (26) | 2i*, BRAFi, SRCi, ROCKi | hLIF, FGF2, Activin A |
Theunissen (31) | 2i (or without GSK3i) BRAFi, SRCi, ROCKi | hLIF, Activin A |
Duggal (38) | 2i | ascorbic acid, forskolin, hLIF, FGF2 |
Carter (39) | (ROCKi) | NME7AB, |
HDACi – sodium butyrate + vorinostat/SAHA